Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | UNK | LA |
Large arm swelling; 101 fever; headache; extreme body aches; she cannot move her arm; This non-serious case was reported by a physician via sales rep and described the occurrence of large arm swelling in a female patient who received Men B NVS (Bexsero) for prophylaxis. In AUG-2025, the patient received Bexsero (left deltoid). On an unknown date, an unknown time after receiving Bexsero, the patient experienced large arm swelling (Verbatim: Large arm swelling), fever (Verbatim: 101 fever), headache (Verbatim: headache), general body pain (Verbatim: extreme body aches) and mobility decreased (Verbatim: she cannot move her arm). The outcome of the large arm swelling was resolving and the outcome of the fever, headache, general body pain and mobility decreased were not reported. The reporter considered the large arm swelling to be related to Bexsero and Bexsero Pre-Filled Syringe Device. It was unknown if the reporter considered the fever, headache, general body pain and mobility decreased to be related to Bexsero and Bexsero Pre-Filled Syringe Device. The company considered the large arm swelling to be related to Bexsero and Bexsero Pre-Filled Syringe Device. It was unknown if the company considered the fever, headache, general body pain and mobility decreased to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 10-SEP-2025 The reporter reported that the patient received Bexsero vaccine and had 101-degree Celsius fever, neck, headache extreme body aches and she cannot move her arm without extreme pain
Test Date: 2025; Test Name: Body temperature; Result Unstructured Data: (Test Result:101,Unit:degree C,Normal Low:,Normal High:)